Cornelis Marilyn C, Fazlollahi Amir, Bennett David A, Schneider Julie A, Ayton Scott
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Department of Radiology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.
J Neurochem. 2025 Feb;169(2):e16309. doi: 10.1111/jnc.16309.
Brain iron (Fe) dyshomeostasis is implicated in neurodegenerative diseases. Genome-wide association studies (GWAS) have identified plausible loci correlated with peripheral levels of Fe. Systemic organs and the brain share several Fe regulatory proteins but there likely exist different homeostatic pathways. We performed the first GWAS of inductively coupled plasma mass spectrometry measures of postmortem brain Fe from 635 Rush Memory and Aging Project (MAP) participants. Sixteen single nucleotide polymorphisms (SNPs) associated with Fe in at least one of four brain regions were measured (p < 5 × 10). Promising SNPs (p < 5 × 10) were followed up for replication in published GWAS of blood, spleen, and brain imaging Fe traits and mapped to candidate genes for targeted cortical transcriptomic and epigenetic analysis of postmortem Fe in MAP. Results for SNPs previously associated with other Fe traits were also examined. Ninety-eight SNPs associated with postmortem brain Fe were at least nominally (p < 0.05) associated with one or more related Fe traits. Most novel loci identified had no direct links to Fe regulatory pathways but rather endoplasmic reticulum-Golgi trafficking (SORL1, SORCS2, MARCH1, CLTC), heparan sulfate (HS3ST4, HS3ST1), and coenzyme A (SLC5A6, PANK3); supported by nearest gene function and omic analyses. We replicated (p < 0.05) several previously published Fe loci mapping to candidate genes in cellular and systemic Fe regulation. Finally, novel loci (BMAL, COQ5, SLC25A11) and replication of prior loci (PINK1, PPIF, LONP1) lend support to the role of circadian rhythms and mitochondria function in Fe regulation more generally. In summary, we provide support for novel loci linked to pathways that may have greater relevance to brain Fe accumulation; some of which are implicated in neurodegeneration. However, replication of a subset of prior loci for blood Fe suggests that genetic determinants or biological pathways underlying Fe accumulation in the brain are not completely distinct from those of Fe circulating in the periphery.
脑铁(Fe)稳态失衡与神经退行性疾病有关。全基因组关联研究(GWAS)已经确定了与外周铁水平相关的可能位点。全身器官和大脑共享几种铁调节蛋白,但可能存在不同的稳态途径。我们对来自635名拉什记忆与衰老项目(MAP)参与者的死后大脑铁进行电感耦合等离子体质谱测量,开展了首次GWAS。测量了在四个脑区中至少一个脑区与铁相关的16个单核苷酸多态性(SNP)(p < 5×10)。对有前景的SNP(p < 5×10)进行后续研究,以在已发表的关于血液、脾脏和脑成像铁性状的GWAS中进行复制,并映射到候选基因,以便对MAP中的死后铁进行靶向皮质转录组学和表观遗传学分析。还检查了先前与其他铁性状相关的SNP的结果。98个与死后大脑铁相关的SNP至少在名义上(p < 0.05)与一种或多种相关铁性状相关。大多数鉴定出的新位点与铁调节途径没有直接联系,而是与内质网 - 高尔基体运输(SORL1、SORCS2、MARCH1、CLTC)、硫酸乙酰肝素(HS3ST4、HS3ST1)和辅酶A(SLC5A6、PANK3)有关;得到最近基因功能和组学分析的支持。我们复制了(p < 0.05)几个先前发表的映射到细胞和全身铁调节候选基因的铁位点。最后,新位点(BMAL、COQ5、SLC25A11)和先前位点的复制(PINK1、PPIF、LONP1)更普遍地支持了昼夜节律和线粒体功能在铁调节中的作用。总之,我们为与可能与脑铁积累更相关的途径相关的新位点提供了支持;其中一些与神经退行性变有关。然而,先前血液铁位点的一部分复制表明,大脑中铁积累的遗传决定因素或生物学途径与外周循环铁的遗传决定因素或生物学途径并非完全不同。